Xiang-Yang (Shawn) Wang, Ph.D., was recently awarded a $316,438 grant from the National Cancer Institute (NCI) to support his studies of tumor recurrence after radiation therapy (RT). The grant was funded after a Massey pilot project discovered preliminary data that established a previously unrecognized feature of an innate receptor in host-tumor interaction during radiotherapy.
Douglas Arthur, MD, associate director for clinical affairs and vice chair of the Department of Radiation Oncology, has been awarded the Natalie N. and John R. Congdon, Sr. Endowed Chair in Cancer Research, in recognition of his significant, ongoing contributions to VCU Massey Cancer Center’s research mission.
Electronic health records (EHRs) hold the promise to improve primary health care for millions of patients. However, enhancing current EHR functionality is needed to better support primary care clinicians and patients, according to a recent article.
Researchers from Massey have discovered a new signaling pathway in sterile inflammation that could impact the treatment of diseases such as cancer, multiple sclerosis and rheumatoid arthritis. Their findings offer insight into the role that activation of interferon-regulatory factor 1 (IRF1), a protein that functions as a transcriptional activator of a variety of target genes, plays in the production of chemokines and the recruitment of mononuclear cells to sites of sterile inflammation.
Matthew Hartman, Ph.D., has focused his research on two hot topics in the arena of cancer research: developing drugs that inhibit key cancer proteins and developing better ways to target cancer tumors. He studies how proteins interact with each other on the molecular level.